Director of Clinical Proteomics & Senior Principal Scientist
Genentech, California
Veronica Anania, PhD is an experienced scientist specializing in biomarker mass spectrometry and clinical proteomics. As Director and Senior Principal Scientist at Genentech, she leads teams in developing biomarker strategies for multiple therapeutic areas including rheumatology and neuroimmunology. Veronica's expertise in quantitative mass spectrometry, biomarker discovery, and assay development has driven innovative research in the field of clinical proteomics. Notable recent achievements from her team include deeply profiling disease proximal samples in large clinical cohorts from patients with IBD, AD, and Multiple Sclerosis to identify non-invasive biomarkers that positively impact drug development and patient care.
Wednesday, October 25, 2023
9:30 AM – 10:00 AM ET